Zydus Cadila gets DCGI nod to start phase 3 trials of Covid-19 vaccine on patients1 min read . Updated: 02 Jan 2021, 08:05 PM IST
- Drug firm Zydus Cadila will conduct the phase 3 clinical trials with its biological therapy 'PegiHep' in Covid-19 patients
Drug firm Zydus Cadila has said that it has received the approval from the Drugs Controller General of India (DCGI) to start the phase 3 clinical trials of the indigenously-developed Covid-19 vaccine on coronavirus patients.
Select your Category